KRT86
Keratin, type II cuticular Hb6
Also known as: Hb6, KRT86_HUMAN, KRTHB6, MNX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43790
- Gene
- KRT86
- Ensembl
- ENSG00000170442
- Chromosome
- 12
- Canonical length
- 486 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a type II keratin protein, which heterodimerizes with type I keratins to form hair and nails. This gene is present in a cluster of related genes and pseudogenes on chromosome 12. Mutations in this gene have been observed in patients with the hair disease monilethrix. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
486 residues, UniProt reviewed canonical sequence.
>O43790|KRT86
1 MTCGSYCGGR AFSCISACGP RPGRCCITAA PYRGISCYRG LTGGFGSHSV CGGFRAGSCG
61 RSFGYRSGGV CGPSPPCITT VSVNESLLTP LNLEIDPNAQ CVKQEEKEQI KSLNSRFAAF
121 IDKVRFLEQQ NKLLETKLQF YQNRECCQSN LEPLFEGYIE TLRREAECVE ADSGRLASEL
181 NHVQEVLEGY KKKYEEEVSL RATAENEFVA LKKDVDCAYL RKSDLEANVE ALIQEIDFLR
241 RLYEEEIRVL QSHISDTSVV VKLDNSRDLN MDCIIAEIKA QYDDIVTRSR AEAESWYRSK
301 CEEMKATVIR HGETLRRTKE EINELNRMIQ RLTAEVENAK CQNSKLEAAV AQSEQQGEAA
361 LSDARCKLAE LEGALQKAKQ DMACLIREYQ EVMNSKLGLD IEIATYRRLL EGEEQRLCEG
421 VGSVNVCVSS SRGGVVCGDL CASTTAPVVS TRVSSVPSNS NVVVGTTNAC APSARVGVCG
481 GSCKRCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KRT86 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 136 nTPM
Expression across tissuesHPA
Tissue
- skin: 136 nTPM
- testis: 3.9 nTPM
- thyroid gland: 3.8 nTPM
- salivary gland: 3.6 nTPM
- blood vessel: 3.3 nTPM
- bone marrow: 2.5 nTPM
Single-cell type
- salivary basal cells: 131 nCPM
- salivary acinar cells: 124 nCPM
- epididymal basal cells: 114 nCPM
- epididymal clear cells: 88 nCPM
- salivary myoepithelial cells: 78 nCPM
- endometrial luminal cells: 73 nCPM
Immune cell
- basophil: 88 nTPM
- NK-cell: 9.7 nTPM
- total PBMC: 0.5 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- white matter: 5 nTPM
- cerebral cortex: 4.2 nTPM
- basal ganglia: 4 nTPM
- hypothalamus: 3.5 nTPM
- midbrain: 3.5 nTPM
- pons: 3.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KRT86.
Disease | AllUniProt
Conditions KRT86 is implicated in, by any mechanism.
- Monilethrix 1 (MNLIX1) MIM:158000
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 161 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Monilethrix
- Monilethrix-1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.27
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KRT86 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KRT86 as an antibody target. Whether an autoantibody or antibody against KRT86 could matter depends on whether native KRT86 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KRT86 is annotated as secreted, so native KRT86 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label KRT86 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...